School of Population Health and Environmental Sciences, King's College London, London; National Institute for Health Research Biomedical Research Centre (BRC), Guy's and St Thomas' NHS Foundation Trust, London.
School of Population Health and Environmental Sciences, King's College London, London.
Br J Gen Pract. 2021 Apr 29;71(706):e331-e338. doi: 10.3399/BJGP.2020.1051. Print 2021 May.
The COVID-19 pandemic has altered the context for antimicrobial stewardship in primary care.
To assess the effect of the pandemic on antibiotic prescribing, accounting for changes in consultations for respiratory and urinary tract infections (RTIs/UTIs).
Population-based cohort study using the UK Clinical Practice Research Datalink (CPRD) GOLD database from January 2017 to September 2020.
Interrupted time-series analysis evaluated changes in antibiotic prescribing and RTI/UTI consultations adjusting for age, sex, season, and secular trends. The authors assessed the proportion of COVID-19 episodes associated with antibiotic prescribing.
There were 253 655 registered patients in 2017 and 232 218 in 2020, with 559 461 antibiotic prescriptions, 216 110 RTI consultations, and 36 402 UTI consultations. Compared with prepandemic months, March 2020 was associated with higher antibiotic prescribing (adjusted rate ratio [ARR] 1.13; 95% confidence interval [CI] = 1.11 to 1.16). Antibiotic prescribing fell below predicted rates between April and August 2020, reaching a minimum in May (ARR 0.73; 95% CI = 0.71 to 0.75). Pandemic months were associated with lower rates of RTI/UTI consultations, particularly in April for RTIs (ARR 0.23; 95% CI = 0.22 to 0.25). There were small reductions in the proportion of RTI consultations with antibiotic prescribed and no reduction for UTIs. Among 25 889 COVID-19 patients, 2942 (11%) had antibiotics within a COVID-19 episode.
Pandemic months were initially associated with increased antibiotic prescribing, which then fell below expected levels during the national lockdown. Findings are reassuring that antibiotic stewardship priorities have not been neglected because of COVID-19. Research is required into the effects of reduced RTI/UTI consultations on incidence of serious bacterial infections.
COVID-19 大流行改变了初级保健中抗菌药物管理的环境。
评估大流行对抗生素处方的影响,同时考虑呼吸道和尿路感染 (RTI/UTI) 就诊的变化。
使用英国临床实践研究数据链接 (CPRD) GOLD 数据库进行的基于人群的队列研究,时间范围为 2017 年 1 月至 2020 年 9 月。
使用中断时间序列分析,调整年龄、性别、季节和长期趋势后,评估抗生素处方和 RTI/UTI 就诊的变化。作者评估了与 COVID-19 相关的抗生素处方比例。
2017 年有 253655 名注册患者,2020 年有 232218 名,开具了 559461 份抗生素处方、216110 份 RTI 就诊和 36402 份 UTI 就诊。与大流行前的月份相比,2020 年 3 月抗生素处方量更高(调整后的比率比 [ARR] 1.13;95%置信区间 [CI] = 1.11 至 1.16)。2020 年 4 月至 8 月期间,抗生素处方量低于预测水平,5 月达到最低值(ARR 0.73;95%CI = 0.71 至 0.75)。大流行月份与 RTI/UTI 就诊率较低相关,尤其是 4 月的 RTI(ARR 0.23;95%CI = 0.22 至 0.25)。与 RTI 就诊相关的抗生素处方比例略有下降,而对于 UTI 则没有下降。在 25889 例 COVID-19 患者中,2942 例(11%)在 COVID-19 发作期间使用了抗生素。
大流行初期与抗生素处方量增加相关,随后在全国封锁期间降至低于预期水平。这些发现令人欣慰,表明 COVID-19 并未忽视抗生素管理的重点。需要研究 RTI/UTI 就诊减少对严重细菌感染发生率的影响。